The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
Department of Medicine II Saarland University Medical Center, Saarland University, Homburg, Germany.|Laboratory of Metabolic Liver Diseases Department of General, Transplant, and Liver Surgery Medical University of Warsaw, Warsaw, Poland.
Marcin
M
Krawczyk
Division of Hepatology, Department of Medicine II University Hospital Würzburg, Würzburg, Germany.
Monika
M
Rau
Department of Medicine II Saarland University Medical Center, Saarland University, Homburg, Germany.
Frank
F
Grünhage
I Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.
Jörn M
JM
Schattenberg
Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Heike
H
Bantel
Department of Internal Medicine IV Gastroenterology and Hepatology, University of Heidelberg, Heidelberg, Germany.
Anita
A
Pathil
Clinic for Gastroenterology and Hepatology, University Hospital of Cologne, Cologne, Germany.
Münevver
M
Demir
I Department of Medicine, Hamburg University Medical Center, Hamburg, Germany.
Johannes
J
Kluwe
Department of Medicine II, Medical Center Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Tobias
T
Boettler
Division of Hepatology, Department of Medicine II University Hospital Würzburg, Würzburg, Germany.
Andreas
A
Geier
Department of Medicine II Saarland University Medical Center, Saarland University, Homburg, Germany.
Frank
F
Lammert
D018435:ATP Binding Cassette Transporter, Subfamily B; D002779:Cholestasis; D006801:Humans; D008103:Liver Cirrhosis
D018435:ATP Binding Cassette Transporter, Subfamily B